Web Results

www.philly.com/philly/business/pharma/20160129_Blue_Bell_firm_wins_approval_for_unique_ADHD_treatment.html

Jan 29, 2016 ... Neos Therapeutics Inc. secured final FDA approval late Wednesday for ... and the bioequivalent of Shire PLC's Adderall XR, said the company, whose local ... to take medicine that dissolves on the tongue "vs. a pill or capsule.

www.philly.com/philly/business/20160517_Neos_Therapeutics__ADHD_drug_is_now_on_the_market.html

May 16, 2016 ... Neos Therapeutics Inc. said Monday that its first-of-a-kind treatment for ... an amphetamine and the bioequivalent of Shire P.L.C.'s Adderall XR.

www.reuters.com/article/brief-neos-therapeutics-enters-into-a-li-idUSFWN1GN0R3

Mar 10, 2017 ... March 10 (Reuters) - Neos Therapeutics Inc. * On March 6, 2017, Neos Therapeutics entered into a license agreement with Shire - SEC filing.

www.scotusblog.com/wp-content/uploads/2017/03/16-341_amicus_resp_pharmaceutical_research_and_manufacturers_of_america.pdf

Mar 8, 2017 ... Acorda Therapeutics, Inc. v. Mylan. Pharm., Inc., 817 ..... 15. Script Sec. Sols. L.L.C. v. Amazon.com,. Inc., 170 F. Supp. 3d 928 (E.D. Tex. 2016) . ... Shire LLC v . Abhai LLC, No. ... 15. Shire LLC v. Neos Theraputics, Inc., No.

www.robinskaplan.com/resources/newsletters/generically-speaking-hatch-waxman-bulletin/generically-speaking-fall-2016/copy-of-new-anda-cases

Koios Pharms. LLC v. Medac Gesellschaft für klinische Spezialpräparate mbH, IPR2016-01370 (PTAB) .... Shire Development LLC v. ... Neos Therapeutics, Inc. v.

www.zacks.com/stock/quote/NEOS

Get the latest Neos Therapeutics, Inc. NEOS detailed stock quotes, stock data, Real-Time ECN, ... Pharma Stock Roundup: NVS Scores with Positive Data, Shire.

www.businesswire.com/news/home/20150428005120/en/Neos-Therapeutics-Appoints-Thomas-P.-McDonnell-Chief

Apr 28, 2015 ... Neos Therapeutics, Inc. (“Neos” or “the Company”), ... Prior to joining Neos, Mr. McDonnell spent 10 years with Shire (NASDAQ: SHPG), most ...

globenewswire.com/news-release/2016/01/28/805288/0/en/Neos-Therapeutics-Announces-FDA-Approval-of-Adzenys-XR-ODT-Amphetamine-Extended-Release-Orally-Disintegrating-Tablet-for-the-Treatment-of-ADHD-in-Patients-6-Years-and-Older.html

Jan 27, 2016 ... January 27, 2016 19:46 ET | Source: Neos Therapeutics, Inc. DALLAS and FORT .... 1 Adderall XR® is registered to Shire plc. 2 National ...

www.neostx.com

Neos Therapeutics, Inc. is a pharmaceutical company focused on the development, manufacturing and commercialization of ADHD medications.